Stocks · US
TWST
XNAS
Twist Bioscience Corporation Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B30.49x
P/S31.48x
EPS$-2.06
ROE-30.67%
ROA-20.33%
Dividend yield0.00%
Debt/Equity0.03
Free cash flow$-98M
Returns and 52-week range
1W-10.29%
1M+33.88%
3M+86.81%
6M+233.14%
1Y+437.40%
YTD+415.50%
52W high$219.71
52W low$23.30
From 52W high-24.01%
Company
HeadquartersSouth San Francisco, CA
Employees979
Listed2018-10-31
Websitewww.twistbioscience.com
SECFilings
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Exelixis Inc | $14.6B | 16.94 | 7.91 | -1.15% |
| Corcept Therapeutics Inc. | $13.2B | 242.09 | 18.69 | +7.12% |
| Neurocrine Biosciences Inc | $14.7B | 20.78 | 3.97 | -6.51% |
| Icon Plc | $13.0B | 38.45 | 6.71 | -1.92% |
| Charles River Laboratories International, Inc. | $14.8B | — | 5.22 | +5.71% |
| BridgeBio Pharma, Inc. Common Stock | $12.9B | — | — | -10.53% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.